Effect of apolipoprotein E4 allele on plasma LDL cholesterol response to diet therapy in type 2 diabetic patients

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1276-1280

  Saito, Mieko ^a   Eto, Masaaki ^a   Nitta, Hayami ^b   Kanda, Yukiko ^a   Shigeto, Makoto ^a   Nakayama, Katsura ^a   Tawaramoto, Kazuhito ^a   Kawasaki, Fumiko ^a   Kamei, Shinji ^a   Kohara, Kenji ^a   Matsuda, Masafumi ^a   Matsuki, Michihiro ^a   Kaku, Kohei ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; DIABETIC DIET; DIET THERAPY; DRUG EFFECT; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 2542453270     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1276     Document Type: Article

References (27)

1. Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Yoshotake T: Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama Study. Diabetes 45 (Suppl. 3):S14-S16, 1996
2. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, Ishii K: Apolipoprotein E polymorphism and hyperlipemia in type II diabetes. Diabetes 35:1374-1382, 1986
3. Eto M, Watanabe K, Iwashima Y, Morikawa A, Chonan N, Oshima E, Sekiguchi M, Ishii K: Increased frequency of apolipoprotein ε4 allele in type II diabetes with hypercholesterolemia. Diabetes 36:1301-1306, 1987
4. Eto M, Watanabe K, Makino I, Ishii K: Apolipoprotein E allele frequency in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipo-proteinemia). Metabolism 40:776-780, 1991
5. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988
6. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM: Apolipoprotein E alleles and risk of coronary heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 16:1250-1255, 1996
7. Eto M, Watanabe K, Ishii K: Increased frequencies of apolipoprotein ε 2 and ε 4 allelels in patients with ischemic heart disease. Clin Genet 36:183-188, 1989
8. Ringer SH: Primary prevention of coronary heart disease by diet. Bull NY Acad Med 44:936-949, 1968
9. Katan MB, Beynen AC: Characteristics of human hypo- and hyperresponders to dietary cholesterol. Am J Epidemiology 125:387-399, 1987
10. Masson LF, McNell G, Avenell A: Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 77:1098-1111, 2003
11. Eto M, Watanabe K, Makino I: Relationship of metabolic control and body weight to hypercholesterolemia in NIDDM patients with apolipoprotein E4. Diabetes Care 14:127-129, 1991
12. Kagawa Y: Food Composition Database. Tokyo, Kagawa Nutrition University Press, 2003
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
14. Hixon JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548, 1990
15. Statistical Analysis System Institute: Stat-View Reference Mannual. Cary, NC, SAS Institute, 1998
16. Nutrition Division, Public Health Service, Ministry of Health, Labour and Welfare, Japan: Nutritional Status of Japanese, Results From the National Nutrition Survey. Japan Food Association, Tokyo, Dai-Ichi Publishing Co., 2003
17. Iwamoto Y, Kasuga M, Kanazawa Y, Sakurai H, Shima K, Totota R, Nanjou K, Kadowaki T: Therapy Guide for Diabetic Patients, 2000 Edition. Tokyo, Japan Diabetes Society, 2000
18. Kita T, Mabuchi H, Itakura H, Ueshima K, Egusa G, Eto M, Kashiwagi A, Sasaki A, Shimamoto K, Suehiro T, Teramoto T, Biro S, Hirobe K, Funahashi T: Guideline for Atherosclerosis Treatment, 2002 Edition. Tokyo, Japan Atherosclerosis Society, 2002
19. Kesaniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80:578-581, 1987
20. Miettinen HE, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein phenotype (Letter). Lancet 2:1261, 1988
21. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schsefer EJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 35:1965-1975, 1994
22. Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Roheim PS, Ramakrishnan R, Derr J, Gordon DJ, Reed R, the DELTA Research Group (Dietary Effects on Lipoproetins and Thrombogenic Activity): ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogenous normolipidemic population. Arterioscler Thromb Vas Biol 17:2914-2923, 1997
23. Eto M, Watanabe K, Ishii K: Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity. Int J Obes 13:433-440, 1989
24. Gregg RE, Zecvh LA, Shaefer EJ, Stark D, Wilson D, Brewer HB Jr: Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821, 1986
25. Lyons TJ: Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiology 71:26B-31B, 1993
26. Murakami K, Shimizu M, Yamada N, Ishibashi S, Shimano H, Yazaki Y, Akanuma Y: Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM. Diabetes Care 16:564-569, 1993
27. Laakso M, Kesaniemi A, Kervinen K, Jauhiainen M, Pyorala K: Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. Br Med J 303:1159-1192, 1991